These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 22418841)

  • 1. [Methods to increase participation in cancer screening programmes].
    Giorgi Rossi P; Camilloni L; Cogo C; Federici A; Ferroni E; Furnari G; Giordano L; Grazzini G; Iossa A; Jimenez B; Palazzi M; Palazzo F; Spadea T; Senore C; Borgia P; Guasticchi G
    Epidemiol Prev; 2012 Jan; 36(1 Suppl 1):1-104. PubMed ID: 22418841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cancer screening programme in health care workers].
    Pisati G; Cerri S; Marinelli M; Tedeschi B; Valsecchi E
    G Ital Med Lav Ergon; 2011; 33(2 Suppl):57-60. PubMed ID: 22187927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors in quality care--the case of follow-up to abnormal cancer screening tests--problems in the steps and interfaces of care.
    Zapka J; Taplin SH; Price RA; Cranos C; Yabroff R
    J Natl Cancer Inst Monogr; 2010; 2010(40):58-71. PubMed ID: 20386054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods to increase participation in organised screening programs: a systematic review.
    Camilloni L; Ferroni E; Cendales BJ; Pezzarossi A; Furnari G; Borgia P; Guasticchi G; Giorgi Rossi P;
    BMC Public Health; 2013 May; 13():464. PubMed ID: 23663511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are smokers less likely to seek preventive healthcare measures in Italy?
    Carreras G; Iannucci L; Costa G; Chellini E; Gorini G
    Eur J Cancer Prev; 2018 Sep; 27(5):507-513. PubMed ID: 28379886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Organized colorectal cancer screening].
    Rouëssé J; Sancho-Garnier H;
    Bull Acad Natl Med; 2014 Feb; 198(2):387-99. PubMed ID: 26263711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the most cost-effective population-based cancer screening program for Chinese women?
    Woo PP; Kim JJ; Leung GM
    J Clin Oncol; 2007 Feb; 25(6):617-24. PubMed ID: 17308266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
    Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
    J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer screening uptake: association with individual characteristics, geographic distribution, and time trends in Italy.
    Carrozzi G; Sampaolo L; Bolognesi L; Sardonini L; Bertozzi N; Giorgi Rossi P; Zappa M; Baldissera S; Campostrini S; Ferrante G; Masocco M; Minardi V; D'Argenzio A; Moghadam PF; Quarchioni E; Ramigni M; Trinito MO; Salmaso S;
    Epidemiol Prev; 2015; 39(3 Suppl 1):9-18. PubMed ID: 26405772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative economics of screening for colorectal cancer, breast cancer and cervical cancer.
    Gyrd-Hansen D
    Crit Rev Oncol Hematol; 1999 Nov; 32(2):133-44. PubMed ID: 10612013
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
    Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
    Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of state-specific Medicaid reimbursement and eligibility policies on receipt of cancer screening.
    Halpern MT; Romaire MA; Haber SG; Tangka FK; Sabatino SA; Howard DH
    Cancer; 2014 Oct; 120(19):3016-24. PubMed ID: 25154930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organizational factors and the cancer screening process.
    Anhang Price R; Zapka J; Edwards H; Taplin SH
    J Natl Cancer Inst Monogr; 2010; 2010(40):38-57. PubMed ID: 20386053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diffusion of screening programmes in Italy, year 2010].
    Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
    Epidemiol Prev; 2012; 36(6 Suppl 1):3-7. PubMed ID: 23293267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
    PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The state of the organized screening in Hungary in 2006].
    Kovács A; Döbrôssy L; Budai A; Cornides A; Boncz I
    Orv Hetil; 2007 Mar; 148(10):435-40. PubMed ID: 17350908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
    Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
    J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer screening before and after switching to a high-deductible health plan.
    Wharam JF; Galbraith AA; Kleinman KP; Soumerai SB; Ross-Degnan D; Landon BE
    Ann Intern Med; 2008 May; 148(9):647-55. PubMed ID: 18458277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of false-positive results for future cancer screenings.
    Taksler GB; Keating NL; Rothberg MB
    Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Costs of population cervical cancer screening program in Poland between 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
    Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.